Abstract

Alanine-serine-cysteine transporter 2 (ASCT2, SLC1A5) is the primary transporter of glutamine in cancer cells and regulates the mTORC1 signaling pathway. The SLC1A5 function involves finely tuned orchestration of two domain movements that include the substrate-binding transport domain and the scaffold domain. Here, we present cryo-EM structures of human SLC1A5 and its complex with the substrate, L-glutamine in an outward-facing conformation. These structures reveal insights into the conformation of the critical ECL2a loop which connects the two domains, thus allowing rigid body movement of the transport domain throughout the transport cycle. Furthermore, the structures provide new insights into substrate recognition, which involves conformational changes in the HP2 loop. A putative cholesterol binding site was observed near the domain interface in the outward-facing state. Comparison with the previously determined inward-facing structure of SCL1A5 provides a basis for a more integrated understanding of substrate recognition and transport mechanism in the SLC1 family.

Data availability

All the cryo-EM data were deposited to the Protein Data Bank (PDB ID: 6MP6, 6MPB) and the EMDB (EMD-9187, EMD-9188) for immediate release upon publication.

The following data sets were generated

Article and author information

Author details

  1. Xiaodi Yu

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Xiaodi Yu, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  2. Olga Plotnikova

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Olga Plotnikova, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  3. Paul D Bonin

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Paul D Bonin, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  4. Timothy A Subashi

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Timothy A Subashi, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  5. Thomas J McLellan

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Thomas J McLellan, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  6. Darren Dumlao

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Darren Dumlao, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  7. Ye Che

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Ye Che, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  8. Yin Yao Dong

    Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  9. Elisabeth P Carpenter

    Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  10. Graham M West

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Graham M West, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  11. Xiayang Qiu

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Xiayang Qiu, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  12. Jeffrey S Culp

    Medicine Design, Pfizer Inc, Groton, United States
    Competing interests
    Jeffrey S Culp, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
  13. Seungil Han

    Medicine Design, Pfizer Inc, Groton, United States
    For correspondence
    seungil.han@pfizer.com
    Competing interests
    Seungil Han, is affiliated with Pfizer Inc. The author has no other competing interests to declare..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1070-3880

Funding

Y.D. and E.P.C. are members of the SGC, (Charity ref: 1097737) funded by AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Merck & Co., Novartis, the Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP and Takeda, as well as the Innovative Medicines Initiative Joint Undertaking ULTRA-DD grant 115766 and the Wellcome Trust106169/Z/14/Z.

Copyright

© 2019, Yu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,927
    views
  • 921
    downloads
  • 56
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xiaodi Yu
  2. Olga Plotnikova
  3. Paul D Bonin
  4. Timothy A Subashi
  5. Thomas J McLellan
  6. Darren Dumlao
  7. Ye Che
  8. Yin Yao Dong
  9. Elisabeth P Carpenter
  10. Graham M West
  11. Xiayang Qiu
  12. Jeffrey S Culp
  13. Seungil Han
(2019)
Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
eLife 8:e48120.
https://doi.org/10.7554/eLife.48120

Share this article

https://doi.org/10.7554/eLife.48120

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Andrew P Latham, Longchen Zhu ... Bin Zhang
    Research Article

    The phase separation of intrinsically disordered proteins is emerging as an important mechanism for cellular organization. However, efforts to connect protein sequences to the physical properties of condensates, that is, the molecular grammar, are hampered by a lack of effective approaches for probing high-resolution structural details. Using a combination of multiscale simulations and fluorescence lifetime imaging microscopy experiments, we systematically explored a series of systems consisting of diblock elastin-like polypeptides (ELPs). The simulations succeeded in reproducing the variation of condensate stability upon amino acid substitution and revealed different microenvironments within a single condensate, which we verified with environmentally sensitive fluorophores. The interspersion of hydrophilic and hydrophobic residues and a lack of secondary structure formation result in an interfacial environment, which explains both the strong correlation between ELP condensate stability and interfacial hydrophobicity scales, as well as the prevalence of protein-water hydrogen bonds. Our study uncovers new mechanisms for condensate stability and organization that may be broadly applicable.

    1. Microbiology and Infectious Disease
    2. Structural Biology and Molecular Biophysics
    Gabriel Magno de Freitas Almeida, Iker Arriaga ... Lotta-Riina Sundberg
    Research Article

    Giant viruses of protists are a diverse and likely ubiquitous group of organisms. Here, we describe Jyvaskylavirus, the first giant virus isolated from Finland. This clade B marseillevirus was found in Acanthamoeba castellanii from a composting soil sample in Jyväskylä, Central Finland. Its genome shares similarities with other marseilleviruses. Helium ion microscopy and electron microscopy of infected cells unraveled stages of the Jyvaskylavirus life cycle. We reconstructed the Jyvaskylavirus particle to 6.3 Å resolution using cryo-electron microscopy. The ~2500 Å diameter virion displays structural similarities to other Marseilleviridae giant viruses. The capsid comprises of 9240 copies of the major capsid protein, encoded by open reading frame (ORF) 184, which possesses a double jellyroll fold arranged in trimers forming pseudo-hexameric capsomers. Below the capsid shell, the internal membrane vesicle encloses the genome. Through cross-structural and -sequence comparisons with other Marseilleviridae using AI-based software in model building and prediction, we elucidated ORF142 as the penton protein, which plugs the 12 vertices of the capsid. Five additional ORFs were identified, with models predicted and fitted into densities that either cap the capsomers externally or stabilize them internally. The isolation of Jyvaskylavirus suggests that these viruses may be widespread in the boreal environment and provide structural insights extendable to other marseilleviruses.